tpst-1120,bevacizumab,ro7247669,atezolizumab,tocilizumab,adg126,tiragolumab
roche,tempest,adagene,jw pharma
['morpheus-liver']
@ 4:54pm cdt dr. richard finn will be presenting during the clinical science symposium: target or tigit in hepatobiliary stop by and hear what dr. finn has to say regarding the results from the morpheus-liver study. #asco23
#clincialtrials
#translationalresearch 
Translational Research In Oncology-US, A Site Management Organization with 14+ sites and access to 200+ Investigators interested in clinical research.